Oral Ketorolac is NOT Approved for a 16-Year-Old with Dental Pain
Oral ketorolac cannot be used in this patient because FDA labeling explicitly states it is not approved for patients under 17 years of age, and it must only be used as continuation therapy following IV/IM administration—not as initial treatment. 1
Why This Patient Cannot Receive Oral Ketorolac
Age Restriction
The FDA drug label is unequivocal: oral ketorolac is "not approved" for patients under 17 years old 1. Your 16-year-old patient falls below this threshold by one year, making this an off-label use that carries medicolegal risk.
Route Sequencing Requirement
Even if the patient were 17 or older, oral ketorolac has a critical prescribing restriction: it can only be given as continuation therapy after IV or IM ketorolac has been initiated 1. The FDA label explicitly states "oral formulation should not be given as an initial dose" 1. For dental pain presenting in an outpatient setting, this requirement cannot be met.
Duration Limitations
The combined duration of IV/IM plus oral ketorolac cannot exceed 5 days in adults 1, with maximum 48 hours recommended in pediatric guidelines 2. This short-term limitation makes it impractical for typical dental pain management.
What You Should Use Instead
For This 16-Year-Old Patient:
- Oral ibuprofen 10 mg/kg every 8 hours is the evidence-based first-line choice 2
- For dental pain specifically, ibuprofen has demonstrated excellent efficacy in this age group
- Alternative: Oral naproxen 5-7.5 mg/kg every 12 hours 2
If IV Ketorolac Were Considered (Inpatient Setting):
In a hospital setting where IV access exists, pediatric dosing would be:
- 0.5-1 mg/kg up to 30 mg as a single intraoperative dose, OR
- 0.15-0.2 mg/kg (max 10 mg) every 6 hours for short-term therapy (maximum 48 hours) 2
Recent evidence suggests even lower doses (0.25-0.5 mg/kg) may provide adequate analgesia with improved safety 3, 4, though this remains under investigation.
Critical Safety Considerations
Why These Restrictions Exist:
Ketorolac carries significant risks that prompted these FDA limitations 1:
- GI ulceration, bleeding, and perforation (dose-dependent risk)
- Postoperative bleeding complications
- Acute renal failure
- Risk increases dramatically with doses >60 mg/day, especially in patients ≥65 years
The Dental Pain Context:
For dental pain, multiple studies demonstrate that oral ibuprofen or other NSAIDs provide equivalent or superior analgesia to opioids 5, 6. A study in postoperative dental pain showed ketorolac 10-20 mg was highly effective 5, but this was in adults where oral ketorolac is approved as continuation therapy.
Bottom Line Algorithm
For your 16-year-old with dental pain:
- Start with oral ibuprofen 10 mg/kg every 8 hours (not to exceed adult dosing)
- Add acetaminophen 10-15 mg/kg every 6 hours if additional analgesia needed
- If inadequate, consider tramadol 1-1.5 mg/kg every 4-6 hours (with appropriate monitoring) 2
- Oral ketorolac is not an option due to age and route restrictions
The only scenario where ketorolac could be used: If this patient were hospitalized, received IV ketorolac first, turned 17 during admission, and required transition to oral medication—an exceptionally unlikely confluence of circumstances.